CH615668A5 - - Google Patents

Download PDF

Info

Publication number
CH615668A5
CH615668A5 CH1866872A CH1866872A CH615668A5 CH 615668 A5 CH615668 A5 CH 615668A5 CH 1866872 A CH1866872 A CH 1866872A CH 1866872 A CH1866872 A CH 1866872A CH 615668 A5 CH615668 A5 CH 615668A5
Authority
CH
Switzerland
Prior art keywords
carbon atoms
formula
phenyl
alkoxy
halogen
Prior art date
Application number
CH1866872A
Other languages
German (de)
English (en)
Inventor
Ulrich Dr Gebert
Ernold Dr Granzer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of CH615668A5 publication Critical patent/CH615668A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
CH1866872A 1971-12-28 1972-12-21 CH615668A5 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2164919A DE2164919C3 (de) 1971-12-28 1971-12-28 Imidazolyl-(2)-carbinole, Verfahren zu ihrer Herstellung und pharmazeutische Präparate

Publications (1)

Publication Number Publication Date
CH615668A5 true CH615668A5 (hu) 1980-02-15

Family

ID=5829419

Family Applications (3)

Application Number Title Priority Date Filing Date
CH1866872A CH615668A5 (hu) 1971-12-28 1972-12-21
CH1397076A CH615920A5 (hu) 1971-12-28 1976-11-05
CH1396976A CH615919A5 (hu) 1971-12-28 1976-11-05

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH1397076A CH615920A5 (hu) 1971-12-28 1976-11-05
CH1396976A CH615919A5 (hu) 1971-12-28 1976-11-05

Country Status (16)

Country Link
US (1) US4213994A (hu)
JP (1) JPS4875575A (hu)
KR (1) KR780000115B1 (hu)
AT (1) AT330764B (hu)
BE (1) BE793407A (hu)
CA (1) CA989845A (hu)
CH (3) CH615668A5 (hu)
DE (1) DE2164919C3 (hu)
ES (1) ES409907A1 (hu)
FR (1) FR2166117B1 (hu)
GB (1) GB1421774A (hu)
IL (1) IL41179A (hu)
NL (1) NL7217517A (hu)
NO (1) NO137123C (hu)
SE (1) SE412388B (hu)
ZA (1) ZA729141B (hu)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
ZA73758B (en) * 1972-02-04 1973-10-31 Gist Brocades Nv A,a-diarylimidazole-2-methanols
FR2292473A1 (fr) * 1974-11-28 1976-06-25 Expandia Sa Derives de benzimidazole utiles en tant que medicaments
FR2467847A1 (fr) * 1979-10-17 1981-04-30 Bouchara Emile Nouveaux derives de l'(hydroxybenzyl)-2 benzimidazole et les compositions pharmaceutiques en contenant
GB2069481B (en) * 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
US4348404A (en) 1980-07-21 1982-09-07 E. I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl-α-polyfluoroalkyl-1H-imidazole-2-methanamines
US4372964A (en) * 1980-10-30 1983-02-08 E. I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl-1H-imidazole-2-methanols
GB2096987B (en) * 1981-04-22 1984-04-04 Farmos Oy Substituted imidazole and imidazole derivatives and their preparation and use
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
US4452987A (en) * 1981-08-20 1984-06-05 Pfizer Inc. Haloacetyl imidazoles
US4532331A (en) * 1983-04-12 1985-07-30 Smithkline Beckman Corporation 1-Benzyl-2-aminomethyl imidazole derivatives
US4661508A (en) * 1984-06-18 1987-04-28 Eli Lilly And Company Aromatase inhibiting α,α-diphenyl-4(5)imidazole-methanes or -ethanes
JPS61145165A (ja) * 1984-12-18 1986-07-02 Mitsubishi Petrochem Co Ltd ベンズイミダゾ−ル誘導体の製造法
FR2613720B1 (fr) * 1987-04-10 1990-01-19 Esteve Labor Dr Derives d'aryl-heteroaryl carbinols avec activite analgesique
US4869838A (en) * 1988-08-25 1989-09-26 Exxon Research And Engineering Company Bis imidazole ethers as metal deactivators
DE4217124A1 (de) * 1992-05-23 1993-11-25 Roehm Gmbh Verfahren zur Herstellung von endständig Stickstoffheterocyclus-substituiertem (Meth)acrylsäureester
US5455359B1 (en) * 1993-10-01 1998-05-05 Res Corp Technologies Inc Metal ion binding monomer and polymer
AU5513298A (en) * 1996-12-20 1998-07-17 Bristol-Myers Squibb Company Heterocyclic inhibitors of microsomal triglyceride transfer protein and method
CA2375843A1 (en) * 1999-06-04 2000-12-14 Qi Zhao Compositions and methods for inhibiting cell death
DE19951701A1 (de) 1999-10-27 2001-05-03 Aventis Pharma Gmbh Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten
US6291499B1 (en) 1999-10-29 2001-09-18 Merck & Co., Inc. 2-cyclohexyl benzimidazole NMDA/NR2B antagonists
US6432976B1 (en) 1999-10-29 2002-08-13 Merck & Co., Inc. 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
US6369076B1 (en) 1999-10-29 2002-04-09 Merck & Co. Inc. 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
US6489477B1 (en) 1999-10-29 2002-12-03 Merck & Co., Inc. 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
US6380205B1 (en) 1999-10-29 2002-04-30 Merck & Co., Inc. 2-cyclohexyl quinazoline NMDA/NR2B antagonists
US6316474B1 (en) * 1999-10-29 2001-11-13 Merck & Co., Inc. 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
US6495561B2 (en) 1999-10-29 2002-12-17 Merck & Co., Inc. 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
AU2007208139B2 (en) * 2006-01-24 2012-09-27 Janssen Pharmaceutica N.V. 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3331739A (en) * 1961-11-01 1967-07-18 Merck & Co Inc 2-substituted benzimidazoles and their use in the inhibition of echo 6 and poliomyelitis
US3652579A (en) * 1969-06-26 1972-03-28 Hoffmann La Roche 1-methyl-2-substituted 5-nitroimidazoles
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
US3812189A (en) * 1972-07-24 1974-05-21 American Cyanamid Co N-(2,2-diloweralkoxyalkyl)-2,2-dilower-alkoxyloweralkanamidines and their acid addition salts

Also Published As

Publication number Publication date
KR780000115B1 (en) 1978-04-15
ES409907A1 (es) 1975-11-16
SE412388B (sv) 1980-03-03
NL7217517A (hu) 1973-07-02
CH615920A5 (hu) 1980-02-29
AT330764B (de) 1976-07-26
DE2164919B2 (de) 1979-08-09
DE2164919C3 (de) 1980-04-10
NO137123C (no) 1978-01-04
FR2166117B1 (hu) 1977-01-28
IL41179A0 (en) 1973-02-28
DE2164919A1 (de) 1973-07-12
ATA1107972A (de) 1975-10-15
NO137123B (no) 1977-09-26
CA989845A (en) 1976-05-25
ZA729141B (en) 1973-09-26
CH615919A5 (hu) 1980-02-29
FR2166117A1 (hu) 1973-08-10
US4213994A (en) 1980-07-22
BE793407A (fr) 1973-06-28
GB1421774A (en) 1976-01-21
JPS4875575A (hu) 1973-10-11
IL41179A (en) 1978-06-15

Similar Documents

Publication Publication Date Title
CH615668A5 (hu)
DE1795836C2 (de) 3-MethyI-2,3,4,4a-tetrahydro-lH- pyrazine [1,2-f] phenanthridin
DE1645971C3 (de) (lndazol-3-yl)-oxyessigsäurederivate, Verfahren zu ihrer Herstellung und Mittel mit entzündungshemmender Wirkung
DE2462367A1 (de) 7-(oxoalkyl)-1,3-dialkylxanthine enthaltende arzneimittelzubereitungen
DE2123923C3 (hu)
DE2634903C2 (de) Tetrahydrothieno-[3,2-c]-pyridin-Derivate und sie enthaltende Arzneimittel
DE3416695A1 (de) Amidinohydrazone von tetralin-, chromon-, thiochromon- und tretrahydrochinolin-derivaten, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
AT391864B (de) Verfahren zur herstellung von neuen 5-pyrimidincarboxamiden und deren additionssalzen
DE2635961A1 (de) Therapeutisch wirksame verbindungen und verfahren zu ihrer herstellung
DE1593027A1 (de) Alkensaeuren und Verfahren zu ihrer Herstellung
DE2921660A1 (de) 5-nitroimidazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende antiprotozoen-mittel
DE2514914A1 (de) Verfahren zur herstellung tertiaerer amine
AT391699B (de) Verfahren zur herstellung neuer 4-chloro substituierter furo-(3,4-c)-pyridinderivate
DE2303176A1 (de) Substituierte 5-chromanole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
DE1906322A1 (de) Neue alpha-Alkyl-5-hydroxytryptophanester
DE2314985A1 (de) 1-(imidazol-1-yl)-isochinoline und verfahren zu ihrer herstellung
DE1910283A1 (de) Arzneimittel mit einem Gehalt an (3,5,3',5'-Tetraoxo)-1,2-dipiperazinoalkanverbindungen und Verfahren zur Herstellung der Verbindungen
DE2024049B2 (de) Alpha-(3,4-dihydroxyphenyl)-alpha(2-piperidinyl)-methanol
AT339896B (de) Verfahren zur herstellung von neuen imidazolyl- (2) -carbinolen und ihren salzen
DE2919553A1 (de) Tetrahydroisochinolinderivat, verfahren zu seiner herstellung und es enthaltende arzneimittel
DE2223051C2 (de) Monohydrat des d(+)-Glucosamids der 1-(p-Chlorbenzoyl)2-methyl-5-methoxy-indolyl-3-essigsäure, Verfahren zu seiner Herstellung und pharmazeutische Zubereitung
DE2536170A1 (de) Neue flavon-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2714561A1 (de) Piperazinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2626889A1 (de) Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2158468A1 (de) Neue Imidazolin-Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate

Legal Events

Date Code Title Description
PL Patent ceased